VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,567 | -61.8% | 2,195 | 0.0% | 0.02% | -60.5% |
Q2 2023 | $53,843 | +5.4% | 2,195 | 0.0% | 0.04% | 0.0% |
Q1 2023 | $51,078 | -8.1% | 2,195 | 0.0% | 0.04% | -11.6% |
Q4 2022 | $55,555 | +32.3% | 2,195 | 0.0% | 0.04% | +26.5% |
Q3 2022 | $42,000 | -25.0% | 2,195 | 0.0% | 0.03% | +6.2% |
Q1 2022 | $56,000 | -39.1% | 2,195 | 0.0% | 0.03% | -34.7% |
Q4 2021 | $92,000 | -4.2% | 2,195 | 0.0% | 0.05% | -12.5% |
Q3 2021 | $96,000 | -7.7% | 2,195 | 0.0% | 0.06% | -3.4% |
Q2 2021 | $104,000 | – | 2,195 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
Capital International Investors | 983,300 | $12,365,000 | 0.00% |
Blackstone Inc. | 35,000 | $440,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |